Role of Serum Vitamin D, Interleukin 13, and microRNA-135a in Hepatocellular Carcinoma and Treatment Failure in Egyptian HCV-Infected Patients Receiving Direct Antiviral Agents.

Direct-acting antivirals (DAAs) are used for hepatitis C virus (HCV) treatment. However, treatment failure and hepatocellular carcinoma (HCC) development following treatment was reported. In this study, we assessed the role of serum vitamin D, interleukin 13 (IL-13), and microRNA-135a in the prediction of treatment failure with DAA and HCC development among Egyptian HCV-infected patients.

The Inc FII Plasmid and its Contribution in the Transmission of and in in Egypt.

The emergence of and producing represents a great problem in many Egyptian hospitals. One hundred and twenty-six . isolates from patients admitted to Assiut University Hospital were identified by an API20E kit.